• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文会议>Biomedical Science amp; Engineering Conference, 2009. BSEC 2009 >“Biomedical innovation lessons learned during the MCAMS discovery process”
【24h】

“Biomedical innovation lessons learned during the MCAMS discovery process”

机译：“在MCAMS发现过程中吸取的生物医学创新经验教训”

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The remote sensing device developed by noninvasive medical technologies, Inc. (NMT), and the integration of several other innovations that create the multiple casualty assessment management system (MCAMS) is a modern day example of technology created to transform physiological data into valuable medical knowledge. Spanning the course of four years, the MCAMS project has yielded multiple innovations and patents. The lessons learned from the discovery process; conceptualization through implementation present an example framework for biomedical system innovation. The Multiple Casualty Assessment Management System is the integration of remote biosensor monitors reporting objective data to redundant receivers that can seamlessly move across the care continuum. The conceptualization process was the most protracted phase of this innovation. Each development stage, from proof of concept to prototype, evaluation, reconceptualization, and finally implementation has been fraught with its own challenges. The key to assuring success in the innovative biomedical process has been focus on the central concern: the patient - the need. While the conceptualization stage was focused on defining relative advantage, throughout the course of the discovery process it was important to reflect on this definition, reevaluate and redefine it. During the development phases of proof of concept and prototype important innovation characteristics were addressed in regard to innovation compatibility and complexity. For example the innovation idea may be compatible with saving lives however the concept of operations was so complex or arduous that it became incompatible with innovation success. Challenges as complex as radar design offer huge advances in biomedical science, however it is simply the ldquoon/offrdquo switch that the end user references the most frequently. Using the MCAMS development process as an example of how to utilize Roger's theory of innovation diffusion, each diffusion characte-nristic will be considered as a part of the biomedical development process; relative advantage, compatibility, complexity, observability and trialability. The author also asserts that current technological tools should include innovation adaptability as a predictor of successful diffusion.
机译：由非侵入性医疗技术有限公司（NMT）开发的遥感设备以及创建多重伤亡评估管理系统（MCAMS）的其他多项创新的集成，是将生理数据转化为有价值的医学知识的现代技术示例。 。 MCAMS项目历时四年，取得了多项创新和专利。从发现过程中学到的教训；通过实施的概念化提出了生物医学系统创新的示例框架。多伤亡评估管理系统是远程生物传感器监控器的集成，可将客观数据报告给冗余接收者，这些接收者可以在整个护理连续过程中无缝移动。概念化过程是这项创新最漫长的阶段。从概念验证到原型开发，评估，重新概念化以及最终实现的每个开发阶段都充满了自身的挑战。确保创新生物医学过程成功的关键一直集中在以下核心问题上：患者-需求。虽然概念化阶段的重点是定义相对优势，但在整个发现过程中，重要的是反思此定义，重新评估和重新定义它。在概念验证和原型的开发阶段，解决了创新兼容性和复杂性方面的重要创新特征。例如，创新理念可能与挽救生命兼容，但是运营理念如此复杂或艰巨，以致与创新成功格格不入。像雷达设计这样复杂的挑战在生物医学领域提供了巨大的进步，但是，最终用户最常引用的仅仅是“切换”。以MCAMS开发过程为例，说明如何利用Roger的创新扩散理论，将每种扩散特性视为生物医学开发过程的一部分；相对优势，兼容性，复杂性，可观察性和可试用性。作者还断言，当前的技术工具应包括创新适应性，作为成功扩散的预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号